About Spastic ataxia-dysarthria due to glutaminase deficiency
Spastic ataxia-dysarthria due to glutaminase deficiency is a rare disease catalogued by Orphanet (ORPHA:557056). It is associated with the GLS gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Spastic ataxia-dysarthria due to glutaminase deficiency trials.
Search ClinicalTrials.gov for "Spastic ataxia-dysarthria due to glutaminase deficiency" or filter by Orphanet code ORPHA:557056 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Spastic ataxia-dysarthria due to glutaminase deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Spastic ataxia-dysarthria due to glutaminase deficiency. Updated daily.